Novartis nominates former Bristol Myers CEO Giovanni Caforio as its new chair. Will M&A deals follow?
Giovanni Caforio, M.D., is lining up a new gig soon after handing all his Bristol Myers Squibb leadership roles over in March. The recent Big Pharma CEO has been proposed as the new chair at Novartis. Caforio, 59, will stand for election as chair of …